Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

Grown Rogue takes majority control of New Jersey cannabis grow

Grown Rogue takes majority control of New Jersey cannabis grow
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Oct 21, 2026 4 min read

Grown Rogue International, a cannabis company with operations across several U.S. states, has tightened its grip on its New Jersey venture. After receiving approval from the New Jersey Cannabis Regulatory Commission (CRC), the company exercised an option to buy an additional 26% stake in ABCO Garden State, bringing its total ownership to 70%. That majority stake also gives Grown Rogue control of ABCO's board, meaning it now has the final say on budgets, hiring, timelines, and reporting.

What the deal actually involves

The transaction is more about governance than new money. Grown Rogue had already advanced roughly $743,000 to ABCO back in 2023 as part of an earlier agreement. This latest step simply converts that previously provided cash into formal equity ownership. In other words, the company isn't writing a fresh check—it's converting an existing financial arrangement into a controlling stake.

Crossing the 50% ownership threshold is significant in corporate terms. It typically signals that a parent company can consolidate the subsidiary's financials and exercise day-to-day operational control. For Grown Rogue, that means it can now direct ABCO's strategy without needing to negotiate with minority partners on major decisions.

Why New Jersey matters for cannabis investors

New Jersey is one of the more attractive markets for cannabis companies in the U.S. The state legalized recreational marijuana in 2021, and its proximity to major population centers like New York City and Philadelphia makes it a key battleground for operators. However, the regulatory environment remains strict, and the CRC has been cautious in issuing licenses and approving changes of control.

Grown Rogue's ability to secure CRC approval for this stake increase is a positive signal, as it shows the company can navigate state oversight. The company has said its Phase II expansion at the New Jersey facility is still on track to be completed by the end of 2026. That expansion is expected to increase cultivation capacity, which could help Grown Rogue meet demand in the region.

What it means for investors

For everyday investors, this news is a reminder that cannabis companies often grow through acquisitions and stake increases rather than just organic sales. Taking majority control of a grow operation can be a way to consolidate supply chains and reduce reliance on third-party producers. It also gives the parent company more flexibility to allocate capital and set production targets.

However, investors should note that this deal doesn't change the company's cash position—the money was already spent. The real impact will come from how effectively Grown Rogue manages ABCO and whether the Phase II expansion delivers the expected capacity and revenue growth. Cannabis stocks remain volatile, and regulatory risk is always present, so any gains from this move will take time to show up in financial results.

The broader cannabis sector has been under pressure in recent years due to high taxes, competition from illicit markets, and slow federal reform. Companies that can secure strong state positions and execute on expansion plans may be better positioned than those that rely on speculative growth. Grown Rogue's move in New Jersey is a step in that direction, but investors should watch for concrete operational updates in the coming quarters.

Looking ahead

With board control secured, Grown Rogue can now move faster on decisions related to the New Jersey operation. The company has not indicated any immediate changes, but it will likely focus on completing Phase II and integrating ABCO's operations with its broader network. Investors will be watching for updates on construction timelines, licensing milestones, and any new supply agreements that could signal revenue growth.

For those following the cannabis space, this deal is a modest but meaningful development. It shows that consolidation is still happening at the state level, even as federal legalization remains stalled. As always, it's important to consider the risks: regulatory changes, market saturation, and the company's ability to execute on its plans. But for now, Grown Rogue has strengthened its position in one of the most promising cannabis markets in the country.

More from this story

Next article · Don't miss

Elevance lifts profit outlook as medical costs cool, membership dips

Elevance Health lifted its full-year profit outlook after a stronger-than-expected third quarter, as medical costs cooled even though membership fell. The insurer's medical loss ratio came in below expectations, signaling pressure may be easing.

Read the story →
Elevance lifts profit outlook as medical costs cool, membership dips